This report provides comprehensive information on the current therapeutic developmental pipeline of Hemispherx Biopharma, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Get Detail Report With TOC @ http://www.researchmoz.us/hemispherx-biopharma-inc-product-pipeline-review-2014-report.html The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

1. Hemispherx Biopharma, Inc. - Product Pipeline Review - 2014
Hemispherx Biopharma, Inc. - Product Pipeline Review - 2014
Summary
Global Markets Directs, Hemispherx Biopharma, Inc. - Product Pipeline Review - 2014, provides an overview of the Hemispherx Biopharma, Inc.s
pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Hemispherx Biopharma, Inc.s, complete with comparative
analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews
latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides brief overview of Hemispherx Biopharma, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Hemispherx Biopharma, Inc.s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major
milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Hemispherx Biopharma, Inc.s pipeline products
Reasons to buy
- Evaluate Hemispherx Biopharma, Inc.s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Hemispherx Biopharma, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Hemispherx Biopharma, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline
in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Hemispherx Biopharma, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Hemispherx Biopharma, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand
business potential and scope
- Explore the dormant and discontinued projects of Hemispherx Biopharma, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table Of Contents
table Of Contents 2
list Of Tables 4
list Of Figures 4
hemispherx Biopharma, Inc. Snapshot 5
hemispherx Biopharma, Inc. Overview 5
key Information 5
key Facts 5
hemispherx Biopharma, Inc. - Research And Development Overview 6
key Therapeutic Areas 6
hemispherx Biopharma, Inc. - Pipeline Review 9
pipeline Products By Stage Of Development 9
pipeline Products - Monotherapy 10
pipeline Products - Combination Treatment Modalities 11
hemispherx Biopharma, Inc. - Pipeline Products Glance 12
Hemispherx Biopharma, Inc. - Product Pipeline Review - 2014

2. hemispherx Biopharma, Inc. - Late Stage Pipeline Products 12
pre-registration Products/combination Treatment Modalities 12
filing Rejected/withdrawn Products/combination Treatment Modalities 13
hemispherx Biopharma, Inc. - Clinical Stage Pipeline Products 14
phase Ii Products/combination Treatment Modalities 14
phase I Products/combination Treatment Modalities 15
hemispherx Biopharma, Inc. - Early Stage Pipeline Products 16
preclinical Products/combination Treatment Modalities 16
hemispherx Biopharma, Inc. - Unknown Stage Pipeline Products 17
unknown Products/combination Treatment Modalities 17
hemispherx Biopharma, Inc. - Drug Profiles 18
interferon Alfa-n3 (human Leukocyte Derived) 18
product Description 18
mechanism Of Action 18
r&d Progress 18
rintatolimod 20
product Description 20
mechanism Of Action 20
r&d Progress 20
alferon Ldo 22
product Description 22
mechanism Of Action 22
r&d Progress 22
interferon Alfa-n3 Injection + Interferon Alfa-n3 Low Dose Oral 24
product Description 24
mechanism Of Action 24
r&d Progress 24
oragen 25
product Description 25
mechanism Of Action 25
r&d Progress 25
hemispherx Biopharma, Inc. - Pipeline Analysis 26
hemispherx Biopharma, Inc. - Pipeline Products By Target 26
hemispherx Biopharma, Inc. - Pipeline Products By Route Of Administration 27
hemispherx Biopharma, Inc. - Pipeline Products By Molecule Type 28
hemispherx Biopharma, Inc. - Pipeline Products By Mechanism Of Action 29
hemispherx Biopharma, Inc. - Recent Pipeline Updates 30
hemispherx Biopharma, Inc. - Dormant Projects 38
hemispherx Biopharma, Inc. - Company Statement 39
hemispherx Biopharma, Inc. - Locations And Subsidiaries 41
head Office 41
other Locations & Subsidiaries 41
hemispherx Biopharma, Inc. - Key Manufacturing Facilities 42
appendix 43
methodology 43
coverage 43
secondary Research 43
primary Research 43
expert Panel Validation 43
contact Us 44
disclaimer 44
list Of Tables
hemispherx Biopharma, Inc., Key Information 5
hemispherx Biopharma, Inc., Key Facts 5
hemispherx Biopharma, Inc. - Pipeline By Indication, 2014 8
hemispherx Biopharma, Inc. - Pipeline By Stage Of Development, 2014 9
hemispherx Biopharma, Inc. - Monotherapy Products In Pipeline, 2014 10
hemispherx Biopharma, Inc. - Combination Treatment Modalities In Pipeline, 2014 11
hemispherx Biopharma, Inc. - Pre-registration, 2014 12
hemispherx Biopharma, Inc. - Filing Rejected/withdrawn, 2014 13
hemispherx Biopharma, Inc. - Phase Ii, 2014 14
hemispherx Biopharma, Inc. - Phase I, 2014 15
hemispherx Biopharma, Inc. - Preclinical, 2014 16
hemispherx Biopharma, Inc. - Unknown, 2014 17
hemispherx Biopharma, Inc. - Pipeline By Target, 2014 26
hemispherx Biopharma, Inc. - Pipeline By Route Of Administration, 2014 27
hemispherx Biopharma, Inc. - Pipeline By Molecule Type, 2014 28
Hemispherx Biopharma, Inc. - Product Pipeline Review - 2014

3. hemispherx Biopharma, Inc. - Pipeline Products By Mechanism Of Action, 2014 29
hemispherx Biopharma, Inc. - Recent Pipeline Updates, 2014 30
hemispherx Biopharma, Inc. - Dormant Developmental Projects,2014 38
hemispherx Biopharma, Inc., Subsidiaries 41
hemispherx Biopharma, Inc., Key Manufacturing Facilities 42
list Of Figures
hemispherx Biopharma, Inc. - Pipeline By Top 10 Indication, 2014 7
hemispherx Biopharma, Inc. - Pipeline By Stage Of Development, 2014 9
hemispherx Biopharma, Inc. - Monotherapy Products In Pipeline, 2014 10
hemispherx Biopharma, Inc. - Pipeline By Top 10 Target, 2014 26
hemispherx Biopharma, Inc. - Pipeline By Top 10 Route Of Administration, 2014 27
hemispherx Biopharma, Inc. - Pipeline By Top 10 Molecule Type, 2014 28
hemispherx Biopharma, Inc. - Pipeline Products By Top 10 Mechanism Of Action, 2014 29
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Hemispherx Biopharma, Inc. - Product Pipeline Review - 2014